Discontinued — last reported Q4 '25

Financing

Other Financing

Biogen Other Financing decreased by 91.9% to $11.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 769.2%, from $1.30M to $11.30M. Over 3 years (FY 2021 to FY 2025), Other Financing shows an upward trend with a 130.4% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2025

How to read this metric

Usually represents minor or non-recurring items; significant fluctuations may warrant investigation into non-standard financing arrangements.

Detailed definition

Captures miscellaneous cash flows related to financing activities that do not fit into primary categories like debt issu...

Peer comparison

Varies widely by company depending on accounting policies and the complexity of the capital structure.

Metric ID: other_financing

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$31.90M-$2.40M$0.00$4.10M$7.30M-$5.50M-$11.50M$16.50M-$16.80M$2.20M-$7.90M$7.30M-$1.30M-$12.60M$1.30M-$1.20M$141.20M$138.70M$11.30M
QoQ Change+92.5%+100.0%+78.0%-175.3%-109.1%+243.5%-201.8%+113.1%-459.1%+192.4%-117.8%-869.2%+110.3%-192.3%>999%-1.8%-91.9%
YoY Change+122.9%-129.2%+302.4%-330.1%+140.0%+31.3%-55.8%+92.3%-672.7%-82.2%+7.7%>999%+769.2%
Range-$31.90M$141.20M
CAGR-20.6%
Avg YoY Growth+109.0%
Median YoY Growth+31.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Biogen's other financing?
Biogen (BIIB) reported other financing of $11.30M in Q1 2026.
How has Biogen's other financing changed year-over-year?
Biogen's other financing increased by 769.2% year-over-year, from $1.30M to $11.30M.
What is the long-term trend for Biogen's other financing?
Over 3 years (2021 to 2025), Biogen's other financing has grown at a 130.4% compound annual growth rate (CAGR), from -$22.90M to $280.00M.
What does other financing mean?
Residual cash flows from financing activities not classified elsewhere.